Campbell Newman Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Buy |
|
|||||
|
2025
Q1 | $3.77M | Sell |
|
|||||
|
2024
Q4 | $2.48M | Sell |
|
|||||
|
2024
Q3 | $2.29M | Sell |
|
|||||
|
2024
Q2 | $1.63M | Sell |
|
|||||
|
2024
Q1 | $1.27M | Buy |
|
|||||
|
2023
Q4 | $1.59M | Buy |
|
|||||
|
2023
Q3 | $1.33M | Sell |
|
|||||
|
2023
Q2 | $1.11M | Buy |
|
|||||
|
2023
Q1 | $1.05M | Buy |
|
|||||
|
2022
Q4 | $979K | Buy |
|
|||||
|
2022
Q3 | $1.2M | Buy |
|
|||||
|
2022
Q2 | $1.08M | Buy |
|
|||||
|
2022
Q1 | $981K | Buy |
|
|||||
|
2021
Q4 | $846K | Buy |
|
|||||
|
2021
Q3 | $819K | Buy |
|
|||||
|
2021
Q2 | $867K | Buy |
|
|||||
|
2021
Q1 | $890K | Buy |
|
|||||
|
2020
Q4 | $932K | Buy |
|
|||||
|
2020
Q3 | $574K | Buy |
|
|||||
|
2020
Q2 | $544K | Buy |
|
|||||
|
2020
Q1 | $381K | Sell |
|
|||||
|
2019
Q4 | $406K | Sell |
|
|||||
|
2019
Q3 | $475K | Sell |
|
|||||
|
2019
Q2 | $378K | Buy |
|
|||||
|
2019
Q1 | $371K | Buy |
|
|||||
|
2018
Q4 | $412K | Buy |
|
|||||
|
2018
Q3 | $387K | Buy |
|